ACOSOG-Z1031: A Phase III Neoadjuvant Trial of Anastrozole versus Letrozole versus Exemestane

ACOSOG-Z1031 (continued)

NSABP-B-40 (continued)

NSABP-B-39 (continued)

IBIS-II (continued)

IBIS-IIB Prevention Trial

IBIS-IIB Prevention (continued)

IBIS-IIB Prevention (continued)

NSABP-B-42 (continued)

CFEM345D2411 (continued)

CAN-NCIC-MA27 (continued)

SOFT (IBCSG-24-02)

SOFT (IBCSG-24-02) (continued)

TEXT (IBCSG-25-02)

TEXT (IBCSG-25-02) (continued)

PERCHE (IBCSG-26-02)

PERCHE (IBCSG-26-02) (continued)

SWOG-S0307 (continued)

SWOG-S0307 (continued)

TAILORx (continued)

TAILORx (continued)

CALGB-49907 (continued)

CALGB-49907 (continued)

CALGB-40101 (continued)

NSABP-B-36 (continued)

SWOG-S0221 (continued)

SWOG-S0221 (continued)

NSABP-B-38 (continued)

NSABP-B-38 (continued)

ECOG-E2104 (continued)

Trial NCT00121134

Trial NCT00121134 (continued)

Trial NCT00121134 (continued)

SoFEA (continued)

SoFEA (continued)

SWOG-S0226 (continued)

SWOG-S0226 (continued)

FACT (continued)

Trial EGF104383

Trial EGF104900

Trial EGF104900 (continued)

CALGB-40503 (proposed)

CALGB-40503 (continued)

CALGB-40503 (continued)

UCLA-0502057-01

UCLA-0502057-01 (continued)

RIBBON 1 (AVF3694g)

RIBBON 1 (AVF3694g) (continued)

RIBBON 1 (AVF3694g) (continued)

RIBBON 2 (AVF3693g)

RIBBON 2 (AVF3693g) (continued)

RIBBON 2 (AVF3693g) (continued)

RIBBON 2 (AVF3693g) (continued)